Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature
Authors
Keywords
-
Journal
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Volume 29, Issue 5, Pages 193-199
Publisher
Mary Ann Liebert Inc
Online
2014-05-09
DOI
10.1089/cbr.2013.1599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan
- (2013) Fabio Minutoli et al. ANNALS OF NUCLEAR MEDICINE
- mTORC1 Inhibitors Suppress Meningioma Growth in Mouse Models
- (2013) D. Pachow et al. CLINICAL CANCER RESEARCH
- The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
- (2013) John J. Zaknun et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Integration of functional neuroimaging in CyberKnife radiosurgery: feasibility and dosimetric results
- (2013) Alfredo Conti et al. Neurosurgical Focus
- Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series
- (2012) Emil Lou et al. JOURNAL OF NEURO-ONCOLOGY
- Atypical and anaplastic meningiomas treated with bevacizumab
- (2012) Lakshmi Nayak et al. JOURNAL OF NEURO-ONCOLOGY
- First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment
- (2012) S. Baldari et al. Pituitary
- Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
- (2012) Michael C Kreissl et al. Radiation Oncology
- Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy
- (2012) Maria Larsson et al. EJNMMI Research
- Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes
- (2011) A. Durand et al. CLINICAL NEUROPATHOLOGY
- Meningioma: review of the literature with emphasis on the approach to radiotherapy
- (2011) Gustavo Nader Marta et al. Expert Review of Anticancer Therapy
- Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
- (2011) Anna Imhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series
- (2011) Marc C. Chamberlain et al. JOURNAL OF NEURO-ONCOLOGY
- Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma
- (2011) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma
- (2011) D. R. Johnson et al. NEURO-ONCOLOGY
- Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report
- (2011) Amir Sabet et al. Radiation Oncology
- Bevacizumab-induced regression of anaplastic meningioma
- (2010) M. J. A. Puchner et al. ANNALS OF ONCOLOGY
- 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging
- (2010) Emilio Bombardieri et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
- (2010) Dik J. Kwekkeboom et al. SEMINARS IN NUCLEAR MEDICINE
- Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
- (2009) Mirco Bartolomei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs
- (2009) Dik J. Kwekkeboom et al. NEUROENDOCRINOLOGY
- Interferon-α for recurrent World Health Organization grade 1 intracranial meningiomas
- (2008) Marc C. Chamberlain et al. CANCER
- Safety and Efficacy of Radionuclide Therapy with High-Activity In-111 Pentetreotide in Patients with Progressive Neuroendocrine Tumors
- (2008) Ebrahim S. Delpassand et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
- (2008) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started